Found 0 matching trials
Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer
PHASE1This is a single-center, open-label, phase I study to assess the safety and...
Location
Moffitt Cancer Center
Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
PHASE1This is a phase I, interventional, single-arm, open-label, dose-finding tre...
Location
Froedtert & the Medical College of Wisconsin
A Study of XZB-0004 in Patients With Solid Tumors
PHASE1XZB-0004 is a novel and potent small molecule inhibitor of receptor tyrosin...
Location
Shanghai Pulmonary Hospital
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia
PHASE2RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics
N/AThe purpose of this observational study is to analyze the extent and charac...
Location
Shandong Provincial Qianfoshan Hospital
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
PHASE1The purpose of this study is to determine the maximum tolerated dose and ef...
Location
Mayo Clinic Arizona
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
PHASE2This is a single-center, single-arm, phase II clinical study to evaluate th...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
PHASE2This study is a prospective, single arm, multi-center phase II clinical tri...
Location
The First Affiliated Hospital of Zhejiang University
Evaluation of Response of Dasatinib to Treat Mastocytosis
PHASE2This is a multicenter, open-label, single arm phase II non-randomized study...
Location
Istituto di ematologia "L e A Seragnoli" - Policlinico universitario Sant'Orsola-Malpighi